1. de Almeida, Bruna O, de Almeida, Larissa C, Costa-Lotufo, Leticia V, Machado-Neto, João A. 2022. ANKHD1 contributes to the malignant phenotype of triple-negative breast cancer cells. In Cell biology international, 46, 1433-1446. doi:10.1002/cbin.11844. https://pubmed.ncbi.nlm.nih.gov/35842770/
2. Sun, Wenhuizi, Huang, Runzhi, Li, Zhenyu, Guo, Yi, Ouyang, Yiqin. 2022. Alternative ANKHD1 transcript promotes proliferation and inhibits migration in uterine corpus endometrial carcinoma. In NPJ genomic medicine, 7, 56. doi:10.1038/s41525-022-00321-0. https://pubmed.ncbi.nlm.nih.gov/36171217/
3. Dhyani, Anamika, Machado-Neto, João A, Favaro, Patricia, Saad, Sara T Olalla. 2014. ANKHD1 represses p21 (WAF1/CIP1) promoter and promotes multiple myeloma cell growth. In European journal of cancer (Oxford, England : 1990), 51, 252-9. doi:10.1016/j.ejca.2014.11.012. https://pubmed.ncbi.nlm.nih.gov/25483783/
4. Yao, Ping-An, Wu, Yong, Zhao, Kui, Cao, Jianping, Xing, Chungen. 2022. The feedback loop of ANKHD1/lncRNA MALAT1/YAP1 strengthens the radioresistance of CRC by activating YAP1/AKT signaling. In Cell death & disease, 13, 103. doi:10.1038/s41419-022-04554-w. https://pubmed.ncbi.nlm.nih.gov/35110552/
5. Yao, Ping'an, Li, Yecheng, Shen, Wenqi, Cao, Jianping, Xing, Chungen. 2018. ANKHD1 silencing suppresses the proliferation, migration and invasion of CRC cells by inhibiting YAP1-induced activation of EMT. In American journal of cancer research, 8, 2311-2324. doi:. https://pubmed.ncbi.nlm.nih.gov/30555746/
6. Machado-Neto, João Agostinho, Lazarini, Mariana, Favaro, Patricia, Olalla Saad, Sara Teresinha, Traina, Fabiola. 2014. ANKHD1 silencing inhibits Stathmin 1 activity, cell proliferation and migration of leukemia cells. In Biochimica et biophysica acta, 1853, 583-93. doi:10.1016/j.bbamcr.2014.12.012. https://pubmed.ncbi.nlm.nih.gov/25523139/
7. Machado-Neto, João Agostinho, Lazarini, Mariana, Favaro, Patricia, Saad, Sara Teresinha Olalla, Traina, Fabiola. 2014. ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cells. In Experimental cell research, 324, 137-45. doi:10.1016/j.yexcr.2014.04.004. https://pubmed.ncbi.nlm.nih.gov/24726915/
8. Dhyani, Anamika, Duarte, Adriana S S, Machado-Neto, João A, Ortega, Manoela Marques, Olalla Saad, Sara T. 2012. ANKHD1 regulates cell cycle progression and proliferation in multiple myeloma cells. In FEBS letters, 586, 4311-8. doi:10.1016/j.febslet.2012.10.037. https://pubmed.ncbi.nlm.nih.gov/23142581/
智鼠故事 
